Journal of Pediatrics Review

Published by: Kowsar

Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014

Mehrnoush Kosaryan 1 and Aily Aliasgharian 1 , *
Authors Information
1 Thalassemia Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: July 28, 2015, 3 (2); e679
  • Published Online: July 20, 2015
  • Article Type: Research Article
  • Received: February 14, 2015
  • Revised: June 10, 2015
  • Accepted: July 5, 2015
  • DOI: 10.17795/jpr-679

To Cite: Kosaryan M, Aliasgharian A. Decrease of Hepatitis C Burden in Patients With Transfusion Dependent Beta Thalassemia Major, Thalassemia Research Center, 1995 – 2014, J Pediatr Rev. 2015 ;3(2):e679. doi: 10.17795/jpr-679.

Copyright © 2015, Mazandaran University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Alavian SM, Tabatabaei SV, Lankarani KB. Epidemiology of HCV infection among thalassemia patients in eastern Mediterranean countries: a quantitative review of literature. Iran Red Cres Med J. 2010; 2010(4): 365-76
  • 2. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med. 2005; 8(2): 84-90
  • 3. Kosaryan M, Saffar M, Khosh Aeen A, Azizi S, Valaii N. The clinical trial of interferon in chronic active hepatitis duo to Hep.C virus in thalassemic patients. J Mazandaran Univ Med Sci. 1999; 24: 13-8
  • 4. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002; 9(5): 390-2[PubMed]
  • 5. Sanei Moghadam E, Rakhshani F, Savad Kouhi S. Prevalence of Hepatitis B and C in patients with major beta-thalassaemia referred to Ali-Asghar Hospital in Zahedan, 1381[in persian]. Sci J Iran Blood Transfus Organ . 2004; 1(1): 1-26
  • 6. Alavi S, Arzanian M, Hatami K, Shirani A. Frequency of hepatitis C in thalassemic patients and its association with liver enzyme, Mofid Hospital, Iran[in persian]. Pajouhesh Dar Pezeshki. 2005; 29(3): 207-11
  • 7. Javadzadeh Shahshahani H, Attar M, Yavari M, Savabieh S. Study of the prevalence of Hepatitis B, C and HIV infection in Hemophilia and Thalassemia population of Yazd[in persian]. Sceitific J Iran Blood Transfus Organ. 2006; 2(7): 315-22
  • 8. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006; 9(4): 319-23[PubMed]
  • 9. Faranoush M, Ghorbani R, Amin BM, Yazdiha M, Malek M. Prevalence of hepatitis C resulted from blood transfusion in major thalassemia patients in Semnan, Damghan and Garmsar. J Hormozgan Univ Med Sci. 2002; 1(10): 77-82
  • 10. Tamaddoni A, Mohammadzadeh I, Ziaei O. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J Allergy Asthma Immunol. 2007; 6(1): 41[PubMed]
  • 11. Akbari A, Imanieh MH, Karimi M, Tabatabaee HR. Hepatitis C virus antibody positive cases in multitransfused thalassemic patients in South of Iran. Hepat Mon. 2007; 7(2): 63-6
  • 12. Ameli M, Besharati S, Nemati K, Zamani F. Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran. Saudi Med J. 2008; 29(11): 1611-5[PubMed]
  • 13. Mahdaviani F, Saremi S, Rafiee M. Prevalence of hepatitis B, C and HIV infection in thalassemic and hemophilic patients of Markazi province in 2004. Sci J Iran Blood Transfus Organ. 2008; 4(5): 313-22
  • 14. Ghafourian Boroujerdnia M, Assareh Zadegan MA, Zandian KM, Haghirizadeh Rodan M. Prevalence of Hepatitis C virus (HCV) among Thalassemia Patients in Khuzestan Province, Southwest Iran. Pak J Med Sci. 2009; 25(1): 113-7
  • 15. Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran. Int J Prev Med. 2012; 3-23[PubMed]
  • 16. Babamahmoodi F, Kosarian M, Babamahmmodi AR, Adnani M. Genotyping and Viral Load Measurements in Patients with Major Thalassemia and Positive Hepatitis C Virus Antibody in Mazandaran Province, Iran. Int J Infect Dise. 2008; 12-8[DOI]
  • 17. Alavian SM, Lankarani KB, Aalaei-Andabili SH, Pouryasin A, Ebrahimi Daryani N, Nassiri Toosi M. Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader's Meeting-28th July 2011-Tehran, IR Iran. Hepat Mon. 2011; 11(9): 703-13[DOI]
  • 18. Alavian SM, Ahmadzad-Asl M, Bagheri Lankarani K, Shahbabaie M, Bahrami Ahmadi A, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009; 9(3): 211-23
  • 19. Samimi-Rad K, Asgari F, Nasiritoosi M, Esteghamati A, Azarkeyvan A, Eslami SM, et al. Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 20. Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin. 2008; 32(3): 263-71[DOI][PubMed]
  • 21. Kosaryan M, Vahidshahi K, Karami H, Forootan MA, Ahangari M. Survival of thalassemic patients referred to the Boo Ali Sina Teaching Hospital, Sari, Iran. Hemoglobin. 2007; 31(4): 453-62[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments